137 related articles for article (PubMed ID: 12500008)
1. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor.
Halpern MD; Dominguez JA; Dvorakova K; Holubec H; Williams CS; Meza YG; Ruth MC; Dvorak B
J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):126-33. PubMed ID: 12500008
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis.
Halpern MD; Holubec H; Dominguez JA; Williams CS; Meza YG; McWilliam DL; Payne CM; McCuskey RS; Besselsen DG; Dvorak B
Pediatr Res; 2002 Jun; 51(6):733-9. PubMed ID: 12032269
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
[TBL] [Abstract][Full Text] [Related]
5. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model.
Dvorak B; Halpern MD; Holubec H; Dvorakova K; Dominguez JA; Williams CS; Meza YG; Kozakova H; McCuskey RS
Pediatr Res; 2003 Mar; 53(3):426-33. PubMed ID: 12595590
[TBL] [Abstract][Full Text] [Related]
6. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
7. Bile acids induce ileal damage during experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Saunders TA; Dvorak K; Clark JA; Doelle SM; Ballatori N; Dvorak B
Gastroenterology; 2006 Feb; 130(2):359-72. PubMed ID: 16472592
[TBL] [Abstract][Full Text] [Related]
8. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
[TBL] [Abstract][Full Text] [Related]
10. Dietary GD3 ganglioside reduces the incidence and severity of necrotizing enterocolitis by sustaining regulatory immune responses.
Xu J; Anderson V; Schwarz SM
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):550-6. PubMed ID: 23783008
[TBL] [Abstract][Full Text] [Related]
11. Ileal immune dysregulation in necrotizing enterocolitis: role of CD40/CD40L in the pathogenesis of disease.
Xu J; Treem WR; Roman C; Anderson V; Rubenstein R; Schwarz SM
J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):140-6. PubMed ID: 21240009
[TBL] [Abstract][Full Text] [Related]
12. Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis.
Liu Y; Zhu L; Fatheree NY; Liu X; Pacheco SE; Tatevian N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G442-50. PubMed ID: 19608731
[TBL] [Abstract][Full Text] [Related]
13. Decreased development of necrotizing enterocolitis in IL-18-deficient mice.
Halpern MD; Khailova L; Molla-Hosseini D; Arganbright K; Reynolds C; Yajima M; Hoshiba J; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G20-6. PubMed ID: 17947451
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis.
Maynard AA; Dvorak K; Khailova L; Dobrenen H; Arganbright KM; Halpern MD; Kurundkar AR; Maheshwari A; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G614-22. PubMed ID: 20539009
[TBL] [Abstract][Full Text] [Related]
15. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
Khailova L; Dvorak K; Arganbright KM; Halpern MD; Kinouchi T; Yajima M; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G940-9. PubMed ID: 20501441
[TBL] [Abstract][Full Text] [Related]
16. Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.
Rentea RM; Welak SR; Fredrich K; Donohoe D; Pritchard KA; Oldham KT; Gourlay DM; Liedel JL
Eur J Pediatr Surg; 2013 Feb; 23(1):39-47. PubMed ID: 23165517
[TBL] [Abstract][Full Text] [Related]
17. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis.
Isani M; Illingworth L; Herman E; Schmidt M; Barron L; Bowling J; Elizee M; Bai I; Gayer C; Grishin A; Erwin CR; Ford HR; Warner BW
J Pediatr Surg; 2018 Jun; 53(6):1203-1207. PubMed ID: 29636182
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
19. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha.
Halpern MD; Clark JA; Saunders TA; Doelle SM; Hosseini DM; Stagner AM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G757-64. PubMed ID: 16269520
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
